Cardisio GmbH, founded in 2016 and headquartered in Frankfurt am Main, is committed to the early detection of heart disease. Cardisiography (CSG) is a method that quickly, precisely, and non-invasively detects pathological patterns that are indicative of heart disease.
Cardisiography is now used in a multitude of practices and clinics, paving the way for simple and reliable early heart disease detection. In addition to the headquarters in Frankfurt, Germany, Cardisio has an office in Berlin and works with sales and distribution partners in several countries.
Our Vision
In Cardisio’s future, everyone has access to a scientifically proven, highly accurate, and non-invasive screening procedure for heart diseases that is easy to use, examiner-independent, and affordable for everyone. We aim to reduce cardiac deaths, complications, and healthcare costs by providing more effective heart exams globally.